Skip to main content
Fig. 2 | Trials

Fig. 2

From: Structural and functional brain biomarkers of clinical response to rTMS of medication-resistant auditory hallucinations in schizophrenia patients: study protocol for a randomized sham-controlled double-blind clinical trial

Fig. 2

Description of the enrolment, treatment, and assessments during the study protocol

AHRS Auditory Hallucinations Rating Scale, BDI Beck Depression Inventory, BDNF brain-derived neurotrophic factor, HCS Hallucination Change Score, MRI magnetic resonance imaging, PANSS Positive And Negative Syndrome Scale, MEP motor-evoked potentials, PSYRATS Psychotic Symptom Rating Scale, rTMS repetitive transcranial magnetic stimulation, t time point, W week.

Back to article page